SEC v. Donald A. Milne III; Instaprin Pharmaceuticals, Inc.; and Island Raceway & Hobby, Inc., No. LR-24484, District of New Jersey (May 30, 2019) — Press Release
raw: Donald A. Milne III, et al.
Donald A. Milne III, et al., No. LR-24484 (D.N.J. May 30, 2019)
Donald A. Milne III and Instaprin Pharmaceuticals, Inc. operated a $4 million offering fraud targeting over 70 investors, many elderly, and consented to pay $3.63 million in disgorgement and interest, and civil penalties of $554,301 and $2.77 million, respectively.
Donald A. Milne III and his company, Instaprin Pharmaceuticals, Inc., allegedly operated a $4 million offering fraud targeting over 70 investors, many of whom were elderly. The SEC charged them with violating anti-fraud and registration provisions of the Securities Act and Exchange Act. Milne and Instaprin consented to pay $3,628,325 in disgorgement and prejudgment interest, and civil penalties of $554,301 and $2,771,493, respectively.
The Securities and Exchange Commission (SEC) charged Donald A. Milne III and his company, Instaprin Pharmaceuticals, Inc., with operating a long-running offering fraud that raised over $4 million from more than 70 investors, many of whom were elderly. The alleged fraud involved Milne misusing investor funds for personal expenses, such as vacations, clothing, spa treatments, divorce expenses, and his defunct remote-controlled toy racecar business, Island Raceway. Instead of using the funds for Instaprin's purported development of a revolutionary fast-acting aspirin, Milne diverted the money to these personal expenses. The SEC alleged violations of anti-fraud and registration provisions under the Securities Act and Exchange Act. Without admitting or denying the allegations, Milne and Instaprin consented to permanent injunctions, $3,628,325 in disgorgement and prejudgment interest, and civil penalties of $554,301 and $2,771,493, respectively. Island Raceway, named as a relief defendant, agreed to pay $941,100 in disgorgement. The settlement awaits court approval.
Exhibits & Attached Documents (1)
Extracted insights
- $4.00M $4 Million $1M–$10M
- $4.00M $4 million $1M–$10M
- $3.63M $3,628,325 $1M–$10M
- $2.77M $2,771,493 $1M–$10M
- $941K $941,100 $100K–$1M
- $554K $554,301 $100K–$1M
- company instaprin pharmaceuticals, inc.
- person Investors
- person offering fraud
- agency Securities and Exchange Commission
- organization Securities and Exchange Commission
- person securities law
- Donald A. Milne III charged running $4 million fraud
- Donald A. Milne III operating long-running offering fraud
- Donald A. Milne III raised $4 million from more than seventy investors
- Donald A. Milne III violator securities law
- Instaprin Pharmaceuticals, Inc. operating long-running offering fraud
- Securities and Exchange Commission filed complaint in federal court in the District of Ne
- Securities and Exchange Commission charged Donald A. Milne III and Instaprin Pharmaceuticals, Inc. with operating a long-running offering fraud that raised over $4 million from more than seventy investors, many of them elderly
- Donald A. Milne III charged with running $4 million fraud
- Donald A. Milne III operated offering fraud
- Instaprin Pharmaceuticals, Inc. involved in offering fraud
- SEC filed complaint in federal court
- SEC charged Donald A. Milne III and Instaprin Pharmaceuticals, Inc.
- fraud raised over $4 million from more than seventy investors
- investors included many elderly individuals
- SEC charges Donald A. Milne III
- SEC charges Instaprin Pharmaceuticals, Inc.
- Donald A. Milne III operated offering fraud
- offering fraud raised $4 million
- offering fraud targeted more than seventy investors
- Securities and Exchange Commission filed complaint federal court in the District of New Jersey
SEC Charges Long Island Recidivist with Running $4 Million Fraud Litigation Release No. 24484 / May 30, 2019 Securities and Exchange Commission v. Donald A. Milne III, et al., No.19-cv-13024 (D.N.J. filed May 29, 2019) The Securities and Exchange Commission charged recidivist securities law violator Donald A. Milne III, of Merrick, New York, and his company, Instaprin Pharmaceuticals, Inc., with operating a long-running offering fraud that raised over $4 million from more than seventy investors, many of them elderly. The SEC's complaint, filed in federal court in the District of New Jersey, alleges that Milne falsely told investors that their money would be used to pay for the operating expenses of Instaprin Pharmaceuticals, which was purportedly developing a revolutionary fast acting aspirin to instantly stop heart attacks and strokes. Instead, Milne allegedly used investors' money to largely pay for personal expenses, such as a vacation, clothing, spa treatments, divorce expenses, and on Island Raceway & Hobby, Inc., his now-defunct remote-controlled toy racecar business, which had previously operated in Lindenhurst, New York. The SEC's complaint charges Milne and Instaprin with violating the anti-fraud provisions of Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and the registration provisions of Section 5(a) and 5(c) of the Securities Act. Without admitting or denying the allegations in the complaint, Milne and Instaprin have consented to the entry of final judgments permanently enjoining them from violating the charged provisions of the federal securities laws, ordering full disgorgement and prejudgment interest of $3,628,325, and imposing civil penalties of $554,301 and $2,771,493, respectively. The SEC's complaint also names Island Raceway as a relief defendant. Island Raceway has consented to the entry of a final judgment agreeing to pay $941,100 in disgorgement and prejudgment interest. The settlement is subject to court approval. The SEC's Retail Strategy Task Force and Office of Investor Education and Advocacy (OIEA) encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool on Investor.gov. Investors can also use the SALI feature to find information about certain people who have had judgments or orders issued against them in SEC court actions or administrative proceedings. The SEC's investigation was conducted by Han Nguyen, Daniel Berman and Kingdon Kase in the Philadelphia office with assistance from Karen M. Klotz and Jennifer Chun Barry, and supervised by Kelly L. Gibson. SEC ComplaintSEC Charges Long Island Recidivist with Running $4 Million Fraud Litigation Release No. 24484 / May 30, 2019 Securities and Exchange Commission v. Donald A. Milne III, et al., No.19-cv-13024 (D.N.J. filed May 29, 2019) The Securities and Exchange Commission charged recidivist securities law violator Donald A. Milne III, of Merrick, New York, and his company, Instaprin Pharmaceuticals, Inc., with operating a long-running offering fraud that raised over $4 million from more than seventy investors, many of them elderly. The SEC's complaint, filed in federal court in the District of New Jersey, alleges that Milne falsely told investors that their money would be used to pay for the operating expenses of Instaprin Pharmaceuticals, which was purportedly developing a revolutionary fast acting aspirin to instantly stop heart attacks and strokes. Instead, Milne allegedly used investors' money to largely pay for personal expenses, such as a vacation, clothing, spa treatments, divorce expenses, and on Island Raceway & Hobby, Inc., his now-defunct remote-controlled toy racecar business, which had previously operated in Lindenhurst, New York. The SEC's complaint charges Milne and Instaprin with violating the anti-fraud provisions of Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and the registration provisions of Section 5(a) and 5(c) of the Securities Act. Without admitting or denying the allegations in the complaint, Milne and Instaprin have consented to the entry of final judgments permanently enjoining them from violating the charged provisions of the federal securities laws, ordering full disgorgement and prejudgment interest of $3,628,325, and imposing civil penalties of $554,301 and $2,771,493, respectively. The SEC's complaint also names Island Raceway as a relief defendant. Island Raceway has consented to the entry of a final judgment agreeing to pay $941,100 in disgorgement and prejudgment interest. The settlement is subject to court approval. The SEC's Retail Strategy Task Force and Office of Investor Education and Advocacy (OIEA) encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool on Investor.gov. Investors can also use the SALI feature to find information about certain people who have had judgments or orders issued against them in SEC court actions or administrative proceedings. The SEC's investigation was conducted by Han Nguyen, Daniel Berman and Kingdon Kase in the Philadelphia office with assistance from Karen M. Klotz and Jennifer Chun Barry, and supervised by Kelly L. Gibson. SEC Complaint